Pharmacy Laws and Rules
Conference (Saturday Only)

Pharmacy Laws and Rules Conference

Saturday, April 13, 2024

Florida Board of Pharmacy Laws and Rules Update                           

8:00-9:30am Consultant/General

Michele Weizer, PharmD, BCPS, XRX Solutions, LLC, President and Owner

Upon completion of this activity, pharmacists will be able to: Review upcoming changes to 64B16.27.797 and 64B16.27.700; Discuss the rule changes that have become effective in 2023, or recently noticed and discussed during the Rules Committee meeting(s); Provide an update on e-Licensing and how to obtain electronic blue license and pharmacy permit; Examine processes associated with emergency orders enacted by the Governor. 

UAN: 0675-0000-24-010-L03-P

Pharmacy Legislative Update 2024                                         

9:30-11:00am Consultant/General

Gallop P. Franklin II, PharmD., BCSCP, Assistant Professor of Pharmacy Practice, Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public health,

Upon completion of this activity, pharmacists will be able to: Describe the recent changes of the 2024 Legislative Session and its effect on the profession of pharmacy; Discuss the steps pharmacy must complete to maintain compliance with current Florida laws; Provide resources the profession may access to remain up to date with current Florida laws.

UAN: 0675-0000-24-011-L03-P

Introduction and Update on USP <797>               

11:15-1:15pm Consultant/General

Gillain Staikos, RPh, CISCI, Senior Pharmacist, Division of Medical Quality Assurance, Florida Department of Health

Upon completion of this activity, pharmacists will be able to: Describe activities that do not fall within the scope of USP 797; Identify key differences between USP<797> of 2008 and USP<797> of 2022; Explain the differences between Category 1, Category 2, and Category 3 Pharmaceutical Compounding Sterile Preparations.

UAN: 0675-0000-24-012-L07-P

USP 795 and 800: Critical Regulations and Key Differences

1:15-2:15pm Consultant/General

Max Everett, Director of Quality, Olympia Compounding Pharmacy

Upon completion of this activity, pharmacists will be able to: Discuss USP <795> and <800> Regulations; Identify key differences between USP <795> and <800> and use results for program related decisions; Identify the components of a Risk Based Approach and be able to implement a Risk-Based Approach. 

UAN: 0675-0000-24-013-L07-P